Author:
Xie Jingjing,Li Zhiling,Jiang Yubao,Tang Dabin,Qiu Xia,Jia Ertao,Zhang Jianyong
Abstract
Polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, and skin changes (POEMS) syndrome is a multisystem disorder that has limited treatment options. Here, we described a case of a 55-year-old female subject who was treated for multiple drugs, but the skin symptoms continued to progress; the patient responded well to baricitinib. This suggests that JAK/STAT signaling pathways play an essential role in the pathological process of POEMS syndrome.
Subject
Pharmacology (medical),Pharmacology
Reference10 articles.
1. POEMS syndrome: clinical update;Brown;J. Neurol.,2019
2. Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis;Di Benedetto;Arthritis Res. Ther.,2021
3. POEMS syndrome: 2017 update on diagnosis, risk stratification, and management;Dispenzieri;Am. J. Hematol.,2017
4. JAK/STAT and VEGF/PAK1 signaling as emerging targets for topical treatment of psoriasis: a pilot study;Du;Int. J. Clin. Exp. Pathol.,2020
5. Vitiligo: mechanisms of pathogenesis and treatment;Frisoli;Annu. Rev. Immunol.,2020